Real-World Experience of Secukinumab Dose Optimization in Moderate-to-Severe Psoriasis. Retrospective, Single-Center Series of 11-Patients Á. Aguado Vázquez, F.J. Melgosa Ramos, C. Alonso Díez, A. Mateu Puchades

Erythrodermic Psoriasis Successfully Treated With Brodalumab: A Case Series F. Mota, P. Mendes-Bastos

Nonscarring Alopecia Secondary to Secukinumab L.L. Tirelli, A. Alfaro, G. Citera, C.M. Echeverría